Alexander C Ford Selected Research

Alexander C Ford Research Topics

Disease

48	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2022 - 11/2008
23	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2021 - 01/2011
19	Constipation 01/2022 - 02/2011
16	Ulcerative Colitis 01/2022 - 06/2010
15	Dyspepsia (Indigestion) 01/2022 - 12/2005
13	Abdominal Pain (Pain, Abdominal) 01/2022 - 11/2008
11	Diarrhea 01/2022 - 08/2014
11	Crohn Disease (Crohn's Disease) 05/2019 - 12/2010
7	Pain (Aches) 12/2021 - 01/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2011
6	Neoplasms (Cancer) 09/2020 - 07/2015
6	Inflammation (Inflammations) 01/2018 - 04/2016
5	Necrosis 12/2021 - 08/2011
5	Opioid-Induced Constipation 10/2019 - 10/2013
5	Peptic Ulcer (Peptic Ulcers) 01/2017 - 09/2004
4	Gastroesophageal Reflux (GERD) 12/2018 - 11/2011
3	Infections 12/2021 - 08/2013
3	Celiac Disease (Celiac Sprue) 01/2017 - 04/2009
2	Nausea 01/2022 - 12/2018
2	Proctitis 07/2021 - 05/2012
2	Gastroparesis 01/2021 - 11/2018
2	Clostridium Infections 11/2019 - 01/2019
2	Hypersensitivity (Allergy) 01/2017 - 01/2016
2	Ulcer 04/2016 - 09/2004
2	Hepatic Encephalopathy 01/2016 - 09/2011
2	Fistula 12/2014 - 04/2011
1	Headache (Headaches) 01/2022
1	Disease Progression 01/2022
1	Proctocolitis (Hemorrhagic Proctocolitis) 07/2021
1	Fatigue 01/2021
1	Obesity 01/2021
1	Sarcopenia 01/2021
1	Microsatellite Instability 09/2020
1	Lactose Intolerance (Intolerance, Lactose) 03/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Sepsis (Septicemia) 11/2019

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 09/2004
10	Infliximab (Remicade)FDA Link 09/2021 - 03/2012
8	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 08/2010
8	Antidepressive Agents (Antidepressants)IBA 01/2020 - 08/2012
6	Neurotransmitter Agents (Neurotransmitter)IBA 12/2021 - 01/2017
6	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 05/2015
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2020 - 01/2011
6	Proton Pump InhibitorsIBA 12/2018 - 03/2008
5	Mesalamine (Mesalazine)FDA LinkGeneric 07/2021 - 12/2010
5	Rifaximin (L 105)FDA Link 01/2020 - 04/2011
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2014
4	Ondansetron (Zofran)FDA LinkGeneric 01/2021 - 07/2015
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 03/2007
4	Parasympatholytics (Antispasmodics)IBA 01/2020 - 11/2008
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020 - 11/2013
4	AcidsIBA 01/2019 - 03/2008
3	C-Reactive ProteinIBA 01/2021 - 10/2016
3	peppermint oilIBA 01/2020 - 11/2008
3	linaclotideIBA 11/2019 - 11/2013
3	Lubiprostone FDA Link 11/2019 - 07/2015
3	Adalimumab (Humira)FDA Link 05/2015 - 08/2011
3	Azathioprine (Imuran)FDA LinkGeneric 02/2015 - 12/2010
2	MonosaccharidesIBA 01/2022 - 01/2018
2	Opioid Analgesics (Opioids)IBA 12/2021 - 07/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2021 - 04/2011
2	tegaserod (Zelnorm)FDA Link 01/2020 - 11/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020 - 01/2014
2	mizagliflozinIBA 11/2019 - 01/2019
2	Imipramine (Janimine)FDA LinkGeneric 12/2018 - 01/2016
2	PrebioticsIBA 11/2018 - 10/2014
2	Serotonin (5 Hydroxytryptamine)IBA 03/2018 - 10/2016
2	Buspirone (Buspar)FDA LinkGeneric 03/2018 - 11/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 08/2011
2	AntibodiesIBA 08/2013 - 04/2009
2	Dihydrotachysterol (AT 10)IBA 06/2012 - 03/2007
1	Amitriptyline (Elavil)FDA LinkGeneric 07/2022
1	OligosaccharidesIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	DisaccharidesIBA 01/2022
1	tofacitinibIBA 12/2021
1	Magnesium Oxide (Magnesia)FDA Link 01/2021
1	SolutionsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	HydrogenIBA 03/2020
1	eluxadolineIBA 01/2020
1	minesaprideIBA 01/2020
1	ramosetron (Nasea)IBA 01/2020
1	alosetron (Lotronex)FDA Link 01/2020
1	Lactulose (Duphalac)FDA LinkGeneric 01/2020
1	plecanatideIBA 11/2019
1	elobixibatIBA 11/2019
1	TD-5108IBA 11/2019

Therapy/Procedure

51	Therapeutics 01/2022 - 09/2004
6	Biological Therapy 12/2021 - 04/2011
4	Colectomy 05/2021 - 05/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2016
2	Activities of Daily Living (ADL) 01/2022 - 01/2022
2	Cholecystectomy 01/2019 - 09/2015
2	Gluten-Free Diet 01/2018 - 01/2017
1	Adjuvant Chemotherapy 09/2020
1	Fecal Microbiota Transplantation 11/2019
1	Length of Stay 11/2019